한글목차

세계의 자동 세포 이미징 시스템 시장 규모는 2024년에 3억 9,500만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 4.2%로 성장하여 2031년까지 5억 3,600만 달러로 확대될 것으로 예측됩니다.

본 보고서는 자동 세포 이미징 시스템에 대한 최근 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호의존성, 공급망 재편 등의 관점에서 종합적인 평가를 제공합니다.

2024년 자동 세포 이미징 시스템 생산량은 1,787대, 평균 가격은 대당 22만 1,000달러입니다.

자동 세포 이미징 시스템은 고함량 이미지 데이터를 다른 실험 데이터세트와 통합하여 정량적이고 실용적인 생물학적 지식을 제공합니다. 이미징 시약, 세정 완충액, 탈색 방지제 등의 소모품은 신뢰할 수 있는 형광 이미징과 신호 안정성을 실현하는 데 기여합니다. 한편, 환경 제어 모듈은 생리적 온도, pH, 산소 수준을 유지하여 이미징 중 세포 생존율을 보장합니다. 이 시스템을 통해 개별 세포의 시간 경과 추적, 표현형 변화 분석, 미표지 생세포의 정량적 이미징, 상처 치유 분석의 자동 평가가 가능합니다.

본 기사에서는 고함량 세포 이미징 분석 시스템(HCS/HCA)에 대해 다루고 있습니다.

자동 세포 이미징 시스템은 생명과학 연구 및 바이오의약품 분야에서 중요한 도구가 되고 있습니다. 그 핵심 장점은 고해상도 현미경과 자동 처리, AI를 활용한 분석을 결합하여 멀티채널 형광 이미징, 장기 생세포 추적, 3D 이미징을 가능하게함으로써 실험 처리량, 데이터 정확도, 재현성을 크게 향상시키는 데 있습니다. 시장을 선도하는 제품으로는 Thermo Fisher Scientific의 CellInsight CX7 고함량 세포 이미징 시스템, EVOS 세포 이미징 시스템, DanaHer 산하 Molecular Devices의 ImageXpress Micro Confocal 등을 들 수 있습니다. 두 시스템 모두 완전 자동 배치 이미징, 지능형 분석, 고처리량 스크리닝을 지원하며, 신약개발, 종양학 연구, 줄기세포 연구, 면역학 등 고부가가치 분야에서 널리 활용되고 있습니다.

세계 주요 제조업체들은 광학 설계, 기계 자동화, 소프트웨어 알고리즘의 심층적인 통합을 통해 높은 기술 장벽을 구축하고, 종합적인 제품 포트폴리오와 데이터 생태계를 통해 시장 우위를 확보하고 있습니다.

이 보고서는 자동 세포 이미징 시스템 세계 시장에 대해 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.

자동 세포 이미징 시스템 시장 규모에 대한 추정 및 예측은 판매량(대수) 및 매출액(백만 달러)의 관점에서 제공되며, 2024년을 기준 연도, 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하고 있습니다. 정량적, 정성적 분석을 통해 독자들이 자동 세포 이미징 시스템 관련 사업 전략 및 성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 자사 포지셔닝 분석, 정보에 입각한 사업적 판단을 내리는데 도움을 드리고자 합니다.

시장 세분화

기업별

• Danaher
• Thermo Fisher Scientific
• Agilent
• Revvity
• Sartorius AG
• Evident Scientific
• Tecan Group
• Fluidigm
• HORIBA Group
• Oxford Instruments
• Yokogawa Electric
• Tow-Int Tech
• CYTENA
• Nanolive
• Axion BioSystems, Inc
• Zeiss
• Blue-Ray Biotech
• Scintica
• NanoEnTek
• Shimadzu Corporation

유형별 부문

• 2D
• 3D

용도별 부문

• 병원
• 학교·연구기관

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동 및 아프리카

영문목차

The global market for Automated Cell Imaging System was estimated to be worth US$ 395 million in 2024 and is forecast to a readjusted size of US$ 536 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Automated Cell Imaging System cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In 2024, the output of automated cell imaging systems will be 1,787 units, with an average price of 221,000 USD/unit.

Automated cellular imaging systems integrate high-content image data with other experimental datasets to deliver quantitative and actionable biological insights. Consumables such as imaging reagents, washing buffers, and anti-fading agents help achieve reliable fluorescence imaging and signal stability, while environmental control modules maintain physiological temperature, pH, and oxygen levels to ensure cell viability during imaging. These systems enable time-lapse tracking of individual cells, phenotype change analysis, quantitative imaging of unlabeled live cells, and automated assessment of wound healing assays.

This article includes high-content cell imaging analysis system (HCS/HCA).

Automated cell imaging systems are becoming key tools in life science research and biopharmaceuticals. Their core advantage lies in combining high-resolution microscopy with automated processing and AI-powered analysis, enabling multi-channel fluorescence, long-term live cell tracking, and 3D imaging, significantly improving experimental throughput, data accuracy, and reproducibility. Leading market products include Thermo Fisher Scientific's CellInsight CX7 high-content cell imaging system and EVOS cell imaging system, as well as Danaher's Molecular Devices' ImageXpress Micro Confocal. All systems support fully automated batch imaging, intelligent analysis, and high-throughput screening, and are widely used in high-value-added fields such as drug discovery, oncology research, stem cell research, and immunology.

Global leading manufacturers have established high technological barriers through the deep integration of optical design, mechanical automation, and software algorithms, and have secured a dominant position in the market through comprehensive product portfolios and data ecosystems.

This report aims to provide a comprehensive presentation of the global market for Automated Cell Imaging System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Automated Cell Imaging System by region & country, by Type, and by Application.

The Automated Cell Imaging System market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Cell Imaging System.

Market Segmentation

By Company

• Danaher
• Thermo Fisher Scientific
• Agilent
• Revvity
• Sartorius AG
• Evident Scientific
• Tecan Group
• Fluidigm
• HORIBA Group
• Oxford Instruments
• Yokogawa Electric
• Tow-Int Tech
• CYTENA
• Nanolive
• Axion BioSystems, Inc
• Zeiss
• Blue-Ray Biotech
• Scintica
• NanoEnTek
• Shimadzu Corporation

Segment by Type

• 2D
• 3D

Segment by Application

• Hospital
• Schools & Research Institutes

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Automated Cell Imaging System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Automated Cell Imaging System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Automated Cell Imaging System in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Automated Cell Imaging System Product Introduction
• 1.2 Global Automated Cell Imaging System Market Size Forecast
  • 1.2.1 Global Automated Cell Imaging System Sales Value (2020-2031)
  • 1.2.2 Global Automated Cell Imaging System Sales Volume (2020-2031)
  • 1.2.3 Global Automated Cell Imaging System Sales Price (2020-2031)
• 1.3 Automated Cell Imaging System Market Trends & Drivers
  • 1.3.1 Automated Cell Imaging System Industry Trends
  • 1.3.2 Automated Cell Imaging System Market Drivers & Opportunity
  • 1.3.3 Automated Cell Imaging System Market Challenges
  • 1.3.4 Automated Cell Imaging System Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Automated Cell Imaging System Players Revenue Ranking (2024)
• 2.2 Global Automated Cell Imaging System Revenue by Company (2020-2025)
• 2.3 Global Automated Cell Imaging System Players Sales Volume Ranking (2024)
• 2.4 Global Automated Cell Imaging System Sales Volume by Company Players (2020-2025)
• 2.5 Global Automated Cell Imaging System Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Automated Cell Imaging System Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Automated Cell Imaging System Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Automated Cell Imaging System
• 2.9 Automated Cell Imaging System Market Competitive Analysis
  • 2.9.1 Automated Cell Imaging System Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Automated Cell Imaging System Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automated Cell Imaging System as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 2D
  • 3.1.2 3D
• 3.2 Global Automated Cell Imaging System Sales Value by Type
  • 3.2.1 Global Automated Cell Imaging System Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Automated Cell Imaging System Sales Value, by Type (2020-2031)
  • 3.2.3 Global Automated Cell Imaging System Sales Value, by Type (%) (2020-2031)
• 3.3 Global Automated Cell Imaging System Sales Volume by Type
  • 3.3.1 Global Automated Cell Imaging System Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Automated Cell Imaging System Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Automated Cell Imaging System Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Automated Cell Imaging System Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Schools & Research Institutes
• 4.2 Global Automated Cell Imaging System Sales Value by Application
  • 4.2.1 Global Automated Cell Imaging System Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Automated Cell Imaging System Sales Value, by Application (2020-2031)
  • 4.2.3 Global Automated Cell Imaging System Sales Value, by Application (%) (2020-2031)
• 4.3 Global Automated Cell Imaging System Sales Volume by Application
  • 4.3.1 Global Automated Cell Imaging System Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Automated Cell Imaging System Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Automated Cell Imaging System Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Automated Cell Imaging System Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Automated Cell Imaging System Sales Value by Region
  • 5.1.1 Global Automated Cell Imaging System Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Automated Cell Imaging System Sales Value by Region (2020-2025)
  • 5.1.3 Global Automated Cell Imaging System Sales Value by Region (2026-2031)
  • 5.1.4 Global Automated Cell Imaging System Sales Value by Region (%), (2020-2031)
• 5.2 Global Automated Cell Imaging System Sales Volume by Region
  • 5.2.1 Global Automated Cell Imaging System Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Automated Cell Imaging System Sales Volume by Region (2020-2025)
  • 5.2.3 Global Automated Cell Imaging System Sales Volume by Region (2026-2031)
  • 5.2.4 Global Automated Cell Imaging System Sales Volume by Region (%), (2020-2031)
• 5.3 Global Automated Cell Imaging System Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Automated Cell Imaging System Sales Value, 2020-2031
  • 5.4.2 North America Automated Cell Imaging System Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Automated Cell Imaging System Sales Value, 2020-2031
  • 5.5.2 Europe Automated Cell Imaging System Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Automated Cell Imaging System Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Automated Cell Imaging System Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Automated Cell Imaging System Sales Value, 2020-2031
  • 5.7.2 South America Automated Cell Imaging System Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Automated Cell Imaging System Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Automated Cell Imaging System Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Automated Cell Imaging System Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Automated Cell Imaging System Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Automated Cell Imaging System Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Automated Cell Imaging System Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Automated Cell Imaging System Sales Value, 2020-2031
  • 6.3.2 United States Automated Cell Imaging System Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Automated Cell Imaging System Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Automated Cell Imaging System Sales Value, 2020-2031
  • 6.4.2 Europe Automated Cell Imaging System Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Automated Cell Imaging System Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Automated Cell Imaging System Sales Value, 2020-2031
  • 6.5.2 China Automated Cell Imaging System Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Automated Cell Imaging System Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Automated Cell Imaging System Sales Value, 2020-2031
  • 6.6.2 Japan Automated Cell Imaging System Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Automated Cell Imaging System Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Automated Cell Imaging System Sales Value, 2020-2031
  • 6.7.2 South Korea Automated Cell Imaging System Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Automated Cell Imaging System Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Automated Cell Imaging System Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Automated Cell Imaging System Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Automated Cell Imaging System Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Automated Cell Imaging System Sales Value, 2020-2031
  • 6.9.2 India Automated Cell Imaging System Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Automated Cell Imaging System Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Danaher
  • 7.1.1 Danaher Company Information
  • 7.1.2 Danaher Introduction and Business Overview
  • 7.1.3 Danaher Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Danaher Automated Cell Imaging System Product Offerings
  • 7.1.5 Danaher Recent Development
• 7.2 Thermo Fisher Scientific
  • 7.2.1 Thermo Fisher Scientific Company Information
  • 7.2.2 Thermo Fisher Scientific Introduction and Business Overview
  • 7.2.3 Thermo Fisher Scientific Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Thermo Fisher Scientific Automated Cell Imaging System Product Offerings
  • 7.2.5 Thermo Fisher Scientific Recent Development
• 7.3 Agilent
  • 7.3.1 Agilent Company Information
  • 7.3.2 Agilent Introduction and Business Overview
  • 7.3.3 Agilent Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Agilent Automated Cell Imaging System Product Offerings
  • 7.3.5 Agilent Recent Development
• 7.4 Revvity
  • 7.4.1 Revvity Company Information
  • 7.4.2 Revvity Introduction and Business Overview
  • 7.4.3 Revvity Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Revvity Automated Cell Imaging System Product Offerings
  • 7.4.5 Revvity Recent Development
• 7.5 Sartorius AG
  • 7.5.1 Sartorius AG Company Information
  • 7.5.2 Sartorius AG Introduction and Business Overview
  • 7.5.3 Sartorius AG Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Sartorius AG Automated Cell Imaging System Product Offerings
  • 7.5.5 Sartorius AG Recent Development
• 7.6 Evident Scientific
  • 7.6.1 Evident Scientific Company Information
  • 7.6.2 Evident Scientific Introduction and Business Overview
  • 7.6.3 Evident Scientific Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Evident Scientific Automated Cell Imaging System Product Offerings
  • 7.6.5 Evident Scientific Recent Development
• 7.7 Tecan Group
  • 7.7.1 Tecan Group Company Information
  • 7.7.2 Tecan Group Introduction and Business Overview
  • 7.7.3 Tecan Group Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Tecan Group Automated Cell Imaging System Product Offerings
  • 7.7.5 Tecan Group Recent Development
• 7.8 Fluidigm
  • 7.8.1 Fluidigm Company Information
  • 7.8.2 Fluidigm Introduction and Business Overview
  • 7.8.3 Fluidigm Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Fluidigm Automated Cell Imaging System Product Offerings
  • 7.8.5 Fluidigm Recent Development
• 7.9 HORIBA Group
  • 7.9.1 HORIBA Group Company Information
  • 7.9.2 HORIBA Group Introduction and Business Overview
  • 7.9.3 HORIBA Group Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 HORIBA Group Automated Cell Imaging System Product Offerings
  • 7.9.5 HORIBA Group Recent Development
• 7.10 Oxford Instruments
  • 7.10.1 Oxford Instruments Company Information
  • 7.10.2 Oxford Instruments Introduction and Business Overview
  • 7.10.3 Oxford Instruments Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Oxford Instruments Automated Cell Imaging System Product Offerings
  • 7.10.5 Oxford Instruments Recent Development
• 7.11 Yokogawa Electric
  • 7.11.1 Yokogawa Electric Company Information
  • 7.11.2 Yokogawa Electric Introduction and Business Overview
  • 7.11.3 Yokogawa Electric Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Yokogawa Electric Automated Cell Imaging System Product Offerings
  • 7.11.5 Yokogawa Electric Recent Development
• 7.12 Tow-Int Tech
  • 7.12.1 Tow-Int Tech Company Information
  • 7.12.2 Tow-Int Tech Introduction and Business Overview
  • 7.12.3 Tow-Int Tech Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Tow-Int Tech Automated Cell Imaging System Product Offerings
  • 7.12.5 Tow-Int Tech Recent Development
• 7.13 CYTENA
  • 7.13.1 CYTENA Company Information
  • 7.13.2 CYTENA Introduction and Business Overview
  • 7.13.3 CYTENA Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 CYTENA Automated Cell Imaging System Product Offerings
  • 7.13.5 CYTENA Recent Development
• 7.14 Nanolive
  • 7.14.1 Nanolive Company Information
  • 7.14.2 Nanolive Introduction and Business Overview
  • 7.14.3 Nanolive Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Nanolive Automated Cell Imaging System Product Offerings
  • 7.14.5 Nanolive Recent Development
• 7.15 Axion BioSystems, Inc
  • 7.15.1 Axion BioSystems, Inc Company Information
  • 7.15.2 Axion BioSystems, Inc Introduction and Business Overview
  • 7.15.3 Axion BioSystems, Inc Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Axion BioSystems, Inc Automated Cell Imaging System Product Offerings
  • 7.15.5 Axion BioSystems, Inc Recent Development
• 7.16 Zeiss
  • 7.16.1 Zeiss Company Information
  • 7.16.2 Zeiss Introduction and Business Overview
  • 7.16.3 Zeiss Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Zeiss Automated Cell Imaging System Product Offerings
  • 7.16.5 Zeiss Recent Development
• 7.17 Blue-Ray Biotech
  • 7.17.1 Blue-Ray Biotech Company Information
  • 7.17.2 Blue-Ray Biotech Introduction and Business Overview
  • 7.17.3 Blue-Ray Biotech Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 Blue-Ray Biotech Automated Cell Imaging System Product Offerings
  • 7.17.5 Blue-Ray Biotech Recent Development
• 7.18 Scintica
  • 7.18.1 Scintica Company Information
  • 7.18.2 Scintica Introduction and Business Overview
  • 7.18.3 Scintica Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.18.4 Scintica Automated Cell Imaging System Product Offerings
  • 7.18.5 Scintica Recent Development
• 7.19 NanoEnTek
  • 7.19.1 NanoEnTek Company Information
  • 7.19.2 NanoEnTek Introduction and Business Overview
  • 7.19.3 NanoEnTek Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.19.4 NanoEnTek Automated Cell Imaging System Product Offerings
  • 7.19.5 NanoEnTek Recent Development
• 7.20 Shimadzu Corporation
  • 7.20.1 Shimadzu Corporation Company Information
  • 7.20.2 Shimadzu Corporation Introduction and Business Overview
  • 7.20.3 Shimadzu Corporation Automated Cell Imaging System Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.20.4 Shimadzu Corporation Automated Cell Imaging System Product Offerings
  • 7.20.5 Shimadzu Corporation Recent Development

8 Industry Chain Analysis

• 8.1 Automated Cell Imaging System Industrial Chain
• 8.2 Automated Cell Imaging System Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Automated Cell Imaging System Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Automated Cell Imaging System Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer